Friday, June 16, 2017
News Recap
Brenda’s Story
Brenda and her husband were forced onto a journey they never wanted to take. Hepatitis C complications put her into a long coma and almost took her life. With luck, love, a generous stranger's liver, and a new hep C cure, she is not only alive but has returned to life with incredible strength and energy. She hopes her story will convince all baby boomers to get tested for hep C, for everyone who has he...
"Just because the donor has hepatitis C, their kidney quality may not be impaired, especially if you can cure the virus. Because the disease exerts its effects very slowly, it’s possible that a young donor or someone in the early stages of the disease may have very few health problems that result from HCV, meaning those kidneys are high-quality."
More than 97,000 people in the United States are currently awaiting kidney transplants—waits that can often ta...
Friday, October-28-16
News in Brief
Restricted Reimbursement for DAAs Hinders Progress Towards Global Hepatitis C Eradication Goal
October 27, 2016
There are significant differences in the criteria for reimbursing for direct-acting antivirals (DAAs) for patients with hepatitis C virus (HCV) among the provinces in Canada, according to the results of a recent study. Conducted by Alison Marshall, MA, of The Kirby Institute, and colleagues, the study...
WASHINGTON -- Some patients facing a years-long wait for a kidney transplant are jumping ahead in line thanks to a startling experiment: They're agreeing to an organ almost sure to infect them with hepatitis C.
Knowingly transmitting a dangerous virus may sound drastic, but two leading transplant centres are betting the strategy will save lives, if new medications that promise to cure hepatitis C allow use of organs that today go to waste.
Pilot studie
Researchers at two universities will target diabetic patients over 60 who have more recently been placed on the waiting list for a kidney donor.Since it was shown hepatitis C could be spread through organ transplants 25 years ago, doctors have shied away from using kidneys from people with the infection -- even to transplant the organs to others with hepatitis C. With drugs available that treat the infection with 95 percent efficacy rates, doctors now feel
